- Title
- Cerebrovascular event (CVE) outcome and overall survival (OS) in patients (pts) treated with sipuleucel-T (sip-T) for metastatic castration-resistant prostate cancer (mCRPC): results from the PROCEED registry
- Creators
- Celestia S. Higano - University of WashingtonAndrew J. Armstrong - Duke Medical CenterA. Oliver Sartor - Tulane Medical School, New Orleans, LANicholas J. Vogelzang - Comprehensive Cancer Centers of NevadaPhilip W. Kantoff - Memorial Sloan Kettering Cancer CenterDavid G. McLeod - Uniformed Services University of the Health SciencesChristopher Michael Pieczonka - SUNY Upstate Medical UniversityDavid F. Penson - Vanderbilt University Medical CenterNeal D. Shore - Carolina Urologic Research CenterJeffrey L. Vacirca - New York Cancer and Blood Specialists, East Setauket, NYLuke T. Nordquist - Urology Cancer Center and GU Research Networket al.
- Publication Details
- Journal of clinical oncology, Vol.36(15_suppl), pp.e17018-e17018
- Identifiers
- 991006262307202656
- Academic Unit
- Radiology
- Language
- English
- Resource Type
- Journal article
Journal article
Cerebrovascular event (CVE) outcome and overall survival (OS) in patients (pts) treated with sipuleucel-T (sip-T) for metastatic castration-resistant prostate cancer (mCRPC): results from the PROCEED registry
Journal of clinical oncology, Vol.36(15_suppl), pp.e17018-e17018
05/20/2018
Metrics
1 Record Views